GlycoMimetics
Patents, Design & Utilities
Last updated:
List of all GlycoMimetics patents 25 in total
| Status | Patent |
|---|---|
Grant | Utility: Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4 Filling date: 26 Sep 2025 Issue date: 6 Sep 2022 |
Application | Utility: METHODS FOR USE OF GENE EXPRESSION AS AN INDICATOR OF E-SELECTIN INHIBITOR EFFICACY AND CLINICAL OUTCOME FOR MULTIPLE TUMOR TYPES Filling date: 26 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: USE OF HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS FOR TREATING SICKLE CELL DISEASE Filling date: 26 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: MULTIMERIC PAN-SELECTIN ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: GALACTOPYRANOSYL-CYCLOHEXYL DERIVATIVES AS E-SELECTIN ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 9 Jun 2022 |
Grant | Utility: E-selectin antagonist compounds, compositions, and methods of use Filling date: 26 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin Filling date: 26 Sep 2025 Issue date: 5 Apr 2022 |
Application | Utility: HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTIN AND GALECTIN-3 Filling date: 26 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: GALECTIN-3 INHIBITING C-GLYCOSIDES Filling date: 26 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists Filling date: 26 Sep 2025 Issue date: 14 Dec 2021 |
Application | Utility: HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 21 Oct 2021 |
Grant | Utility: Highly potent multimeric e-selectin antagonists Filling date: 26 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Glycomimetic inhibitors of PA-IL and PA-IIL lectins Filling date: 26 Sep 2025 Issue date: 29 Jun 2021 |
Application | Utility: METHODS OF MOBILIZING MARROW INFILTRATING LYMPHOCYTES AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: METHODS FOR TREATING ACUTE MYELOID LEUKEMIA AND RELATED CONDITIONS Filling date: 26 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTIN AND GALECTIN-3 Filling date: 26 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: HALOALKYL FUCOSE-CONTAINING SELECTIN ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: E-selectin antagonist compounds, compositions, and methods of use Filling date: 26 Sep 2025 Issue date: 8 Sep 2020 |
Application | Utility: Heterobifunctional Pan-Selectin Antagonists Having a Triazole Linker Filling date: 26 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: GALACTOPYRANOSYL-CYCLOHEXYL DERIVATIVES AS E-SELECTIN ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 30 Apr 2020 |
Grant | Utility: E-selectin antagonist compounds, compositions, and methods of use Filling date: 26 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors Filling date: 26 Sep 2025 Issue date: 31 Dec 2019 |
Application | Utility: HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 1 Aug 2019 |
Showing 1 to 25 of 25 patents.